ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Post-Acute COVID-19 Syndrome
Syndrome
Pneumonia

COVID-19 trials near Boston, MA, USA:

Defibrotide for the Treatment of Severe COVID-19

The goal of this study is to evaluate the safety and feasibility of defibrotide in COVID-19 pneumonia....

Enrolling
Covid19
Drug: Defibrotide

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States

The proposed trial will obtain preliminary data on the feasibility of studying RTB101 as compared to placebo for COVID-19 post-expo...

Active, not recruiting
Covid19
Drug: Placebo
Drug: RTB101

Phase 2

resTORbio

Roslindale, Massachusetts, United States and 1 other location

. There are no established monitoring nationwide protocols for COVID-19 prevention of infection. Due to the lack of such protocols,-...

Enrolling
COVID-19 Respiratory Infection
Diagnostic Test: SARS CoV-2 antigen tests

Phase 1

IDX20

Chelsea, Massachusetts, United States

A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...

Active, not recruiting
COVID-19
SARS-CoV-2
Drug: VYD222 (pemivibart)
Drug: Normal saline

Phase 3

Invivyd

Burlington, Massachusetts, United States and 17 other locations

The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...

Active, not recruiting
COVID-19
Biological: mRNA-1283.222
Biological: mRNA-1273.815

Phase 3

Moderna
Moderna

Boston, Massachusetts, United States and 217 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Boston, Massachusetts, United States and 214 other locations

be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 1

Pfizer
Pfizer

Boston, Massachusetts, United States and 32 other locations

assess preliminary effectiveness of the intervention to increase COVID-19 vaccine intention among parents of under-vaccinated child...

Enrolling
COVID-19 Vaccination
Behavioral: CONFIDENCE
University of Massachusetts, Worcester

Worcester, Massachusetts, United States

Locations recently updated

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Boston, Massachusetts, United States and 66 other locations

Locations recently updated

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 2, Phase 3

Pfizer
Pfizer

Boston, Massachusetts, United States and 109 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems